V03 Stock Analysis: VENTURE | SG

Electronic Components | SG, Singapore | Market Cap: 4.905m SGD | 12M Return: 52% | Charts, Fundamentals & Technical Analysis

Medical Devices, Networking Equipment, Test Equipment, Computer Peripherals
Total Rating 56
Safety 84
Buy Signal 0.66
Electronic Components
Industry Rotation: -18.2
Market Cap: 3.79B
Avg Turnover: 16.4M
Risk 3d forecast
Volatility19.6%
VaR 5th Pctl3.15%
VaR vs Median-2.37%
Reward TTM
Sharpe Ratio1.60
Rel. Str. IBD72.2
Rel. Str. Peer Group25
Character TTM
Beta0.720
Beta Downside0.632
Hurst Exponent0.450
Drawdowns 3y
Max DD31.91%
CAGR/Max DD0.33
CAGR/Mean DD1.15

Warnings

No concerns identified

Tailwinds

Idiosyncratic Leader

Seasonality 10.5 years of data

Jan +1.4% 34
Feb +0.1% 0
Mar +1.4% 15
Apr -1.1% 14
May -0.9% 11
Jun -0.5% 16
Jul +4.6% 26
Aug +2.7% 35
Sep -2.7% 26
Oct -0.7% 8
Nov -0.7% 20
Dec +0.6% 9

How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.

Description: V03 VENTURE

Venture Corporation Limited (V03) is a Singapore-based technology solutions provider that offers manufacturing, product design and development, engineering, and supply-chain management services to customers across the Asia Pacific and international markets. The company operates as an Electronics Manufacturing Services (EMS) provider, an outsourcing model in which third-party firms handle production, assembly, and related services for original equipment manufacturers across multiple end markets.

Its operations span a broad range of activities, including the manufacture and assembly of electronic components, printed circuit board assemblies, sub-assemblies, and finished products serving communication and networking equipment, medical and scientific instrumentation, consumer electronics, measuring and testing equipment, optical instruments, and medical devices. The group also conducts research and experimental development in biotechnology and life and medical sciences, reflecting diversification into higher-value engineering segments beyond traditional contract manufacturing.

Founded in 1984 and headquartered in Singapore, Venture maintains a wide operational footprint that includes wholesale distribution of computer hardware, customization and logistics services, mould and precision plastic component manufacturing, and the letting of factory buildings, supporting its vertically integrated service offering for global technology customers.

Headlines to Watch Out For
  • Medical device segment accelerates revenue diversification beyond consumer electronics
  • Component cost inflation pressures manufacturing services margins
  • Networking equipment demand strengthens on 5G and data center capex
Piotroski VR-10 (Strict) 6.0
Net Income: 227.0m TTM > 0 and > 6% of Revenue
FCF/TA: 0.06 > 0.02 and ΔFCF/TA -6.38 > 1.0
NWC/Revenue: 73.06% < 20% (prev 71.00%; Δ 2.06% < -1%)
CFO/TA 0.07 > 3% & CFO 251.5m > Net Income 227.0m
Net Debt (-1.26b) to EBITDA (413.7m): -3.06 < 3
Current Ratio: 3.34 > 1.5 & < 3
Outstanding Shares: last quarter (287.7m) vs 12m ago -0.94% < -2%
Gross Margin: 27.62% > 18% (prev 25.95%; Δ 1.67% > 0.5%)
Asset Turnover: 69.35% > 50% (prev 73.90%; Δ -4.54% > 0%)
Interest Coverage Ratio: 386.4 > 6 (EBIT TTM 379.8m / Interest Expense TTM 983k)
Altman Z'' 9.68
A: 0.51 (Total Current Assets 2.64b - Total Current Liabilities 791.6m) / Total Assets 3.60b
B: 0.60 (Retained Earnings 2.17b / Total Assets 3.60b)
C: 0.10 (EBIT TTM 379.8m / Avg Total Assets 3.65b)
D: 3.47 (Book Value of Equity 2.79b / Total Liabilities 804.4m)
Altman-Z'' = 9.68 = AAA
Beneish M -3.13
DSRI: 0.98 (Receivables 608.8m/667.6m, Revenue 2.53b/2.73b)
GMI: 0.94 (GM 25.95% / 27.62%)
AQI: 1.03 (AQ_t 0.19 / AQ_t-1 0.19)
SGI: 0.93 (Revenue 2.53b / 2.73b)
TATA: -0.01 (NI 227.0m - CFO 251.5m) / TA 3.60b)
Beneish M = -3.13 (Cap -4..+1) = AA
What is the price of V03 shares?

As of July 10, 2026, the stock is trading at SGD 16.93 with a total of 842,500 shares traded. Over the past week, the price has changed by -2.03%, over one month by -3.26%, over three months by +11.44% and over the past year by +52.04%.

Current recommended Stop Loss: 16.50 (which is 2.5% or 1.3 ATR below the current price).

Is V03 a buy, sell or hold?

VENTURE has no consensus analysts rating.

VENTURE (V03) - Fundamental Data Overview as of 07 July 2026
Market Cap USD = 3.79b (4.91b SGD * 0.7735 SGD.USD)
P/E Trailing = 21.5949
P/E Forward = 20.2429
P/S = 1.9354
P/B = 1.7791
P/EG = 2.5322
Revenue TTM = 2.53b SGD
EBIT TTM = 379.8m SGD
EBITDA TTM = 413.7m SGD
 Long Term Debt = unknown (none)
 Short Term Debt = unknown (none)
 Debt = 19.6m SGD (Leases only: 19.6m)
Net Debt = -1.26b SGD (calculated: Debt 19.6m - CCE 1.28b)
Enterprise Value = 3.64b SGD (4.91b + Debt 19.6m - CCE 1.28b)
Interest Coverage Ratio = 386.4 (Ebit TTM 379.8m / Interest Expense TTM 983k)
EV/FCF = 16.29x (Enterprise Value 3.64b / FCF TTM 223.5m)
FCF Yield = 6.14% (FCF TTM 223.5m / Enterprise Value 3.64b)
FCF Margin = 8.83% (FCF TTM 223.5m / Revenue TTM 2.53b)
Net Margin = 8.96% (Net Income TTM 227.0m / Revenue TTM 2.53b)
Gross Margin = 27.62% ((Revenue TTM 2.53b - Cost of Revenue TTM 1.83b) / Revenue TTM)
Gross Margin QoQ = none% (prev none%)
Tobins Q-Ratio = 1.01 (Enterprise Value 3.64b / Total Assets 3.60b)
Interest Expense / Debt = 5.01% (Interest Expense 983k / Debt 19.6m)
Taxrate = 19.96% (56.8m / 284.4m)
NOPAT = 304.0m (EBIT 379.8m * (1 - 19.96%))
Current Ratio = 3.34 (Total Current Assets 2.64b / Total Current Liabilities 791.6m)
Debt / Equity = 0.01 (Debt 19.6m / totalStockholderEquity, last quarter 2.79b)
Debt / EBITDA = -3.06 (Net Debt -1.26b / EBITDA 413.7m)
Debt / FCF = -5.66 (Net Debt -1.26b / FCF TTM 223.5m)
Total Stockholder Equity = 2.82b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.22% (Net Income 227.0m / Total Assets 3.60b)
RoE = 8.05% (Net Income TTM 227.0m / Total Stockholder Equity 2.82b)
RoCE = 13.51% (EBIT 379.8m / Capital Employed (Total Assets 3.60b - Current Liab 791.6m))
RoIC = 11.33% (NOPAT 304.0m / Invested Capital 2.68b)
WACC = 8.50% (E(4.91b)/V(4.92b) * Re(8.52%) + D(19.6m)/V(4.92b) * Rd(5.01%) * (1-Tc(0.20)))
Discount Rate = 8.52% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 51.11 | Cagr: 0.39%
[DCF] Terminal Value 72.53% ; FCFF base≈320.4m ; Y1≈281.0m ; Y5≈227.0m
[DCF] Fair Price = 16.76 (EV 3.55b - Net Debt -1.26b = Equity 4.82b / Shares 287.5m; r=8.50% [WACC]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 0.99 | # QB: 2
Revenue Correlation: -99.70 | Revenue CAGR: -8.49% | SUE: N/A | # QB: 0
EPS current Year (2026-12-31): EPS=0.85 | Chg30d=-1.16% | Revisions=+25% | GrowthEPS=+8.0% | GrowthRev=+5.5%
EPS next Year (2027-12-31): EPS=0.91 | Chg30d=-1.09% | Revisions=+25% | GrowthEPS=+6.5% | GrowthRev=+5.3%
[Analyst] Revisions Ratio: +40% (up=2, down=0)